Lilly wins recognition for work against TB
20 Nov 2008
Eli Lilly and the International Council of Nurses (ICN) have been recognised for their joint work in combating tuberculosis (TB).
They were awarded a corporate citizenship prize at the US Chamber of Commerce Business Civic Leadership Centre's 9th annual dinner.
A new online voting system decided on the prize-winners, with Lilly and the ICN gaining credit for their actions against the rising global threat of multidrug-resistant strains of the disease (MDR-TB).
"Stopping MDR-TB is not about a single action - it's about a series of joint initiatives that improve survival for some of the world's most vulnerable ... patients," said John Lechleiter, the company's president and chief executive officer.
Dave Benton, chief executive officer of the ICN, stressed that nurses represent the world's "front-line resource" in the fight against a number of deadly global pandemics.
Meanwhile Eli Lilly employees and retirees have made a significant donation to charity, the company has announced.
As a result of their efforts, president and chief executive officer of the drugs giant John Lechleiter presented an $11.1 million (£7.5 million) cheque to the United Way of Central Indiana.
